Merck & Co.
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Merck & Co. (MRK) Business News
Track Merck & Co. in real time with a live news feed covering Merck & Co. stock news, official press releases, company announcements, and an archive of historical Merck & Co. news. ...more
-
CalendarDateSuMoTuWeThFrSaSelected FilterNo selection
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
Prediction: These Could Be the Best-Performing Value Stocks Through 2030
Ameritas Advisory Services LLC Has $1.16 Million Holdings in Merck & Co., Inc. $MRK
MRK Up More Than 7% on Improved Long-Term Prospects: Still a Sell?
Is Merck (MRK) a Buy as Wall Street Analysts Look Optimistic?
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know
Stock Market Live February 13, 2026: S&P 500 (SPY) Fighting to Go Green
Merck: Keytruda Remains Resilient Despite LOE Risks - Buy Upon Correction
Caprock Group LLC Invests $5.33 Million in Merck & Co., Inc. $MRK
Merck Advances Treatment of Bladder and Kidney Cancers with New Data at 2026 ASCO GU Cancers Symposium
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
8:15 AM | Saturday | Feb 14, 2026
Markets are choppy in 2026, and many investors believe we could see a correction this year. Investors should be prepared with defensive stocks that generate reliable dividends.
Read full article
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
The Motley FoolMarkets are choppy in 2026, and many investors believe we could see a correction this year. Investors should be prepared with defensive stocks that generate reliable dividends.
Read full article
Prediction: These Could Be the Best-Performing Value Stocks Through 2030
The Motley FoolInvestors are fearful of Uber Technologies' slowing growth and upcoming spending on autonomous vehicles. This, however, is exactly where the company needs to invest.
Read full article
Ameritas Advisory Services LLC Has $1.16 Million Holdings in Merck & Co., Inc. $MRK
Defense WorldAmeritas Advisory Services LLC trimmed its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 52.6% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 13,857 shares of the company's stock after selling 15,380 shares during the period.
Ameritas Advisory Services LLC's
MRK Up More Than 7% on Improved Long-Term Prospects: Still a Sell?
Zacks Investment ResearchMerck stock has risen more than 7% in a month on a stronger long-term outlook, but 2026 headwinds, Keytruda patent risk and Gardasil slump keep it a Sell.
Read full article
Is Merck (MRK) a Buy as Wall Street Analysts Look Optimistic?
Zacks Investment ResearchThe recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Read full article
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know
Zacks Investment ResearchRecently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock has in store.
Read full article
Stock Market Live February 13, 2026: S&P 500 (SPY) Fighting to Go Green
247 WallstLive Updates Here's why lithium stocks could rocket higher 2 hours ago Live The lithium story is getting explosive - again. For one, lithium remains one of the most strategically important commodities for the global shift to electrification, clean energy, and energy storage. Unfortunately, lithium is shifting from oversupply to a tight deficit again. In fact, as..
. Stock Market Live February 13, 2026: S&P 500 (SPY) Fighting to Go Green.
Merck: Keytruda Remains Resilient Despite LOE Risks - Buy Upon Correction
Seeking AlphaNew KEYTRUDA indications are expected to preserve Merck's top line, significantly aided by the high single-digit Animal Health/Livestock and the triple-digit Winrevair revenue growth in FY2025. KEYTRUDA QLEX, with the expected ~20Y monopoly on injection delivery and the projected ~40% user transition by 2027, is positioned to bridge revenue risks after the original KEYTRUDA's 2028 LOE. MRK's healthier balance sheet, secure dividends, and disciplined capital allocation support resilience, despite the lumpy intermediate-term adjusted EPS prospects.
Read full article
Caprock Group LLC Invests $5.33 Million in Merck & Co., Inc. $MRK
Defense WorldCaprock Group LLC acquired a new stake in Merck and Co., Inc. (NYSE: MRK) during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 63,387 shares of the company's stock, valued at approximately $5,332,000. A number of other large investors also recently bought
Read full article
Merck Advances Treatment of Bladder and Kidney Cancers with New Data at 2026 ASCO GU Cancers Symposium
Business WireRAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck Advances Treatment of Bladder and Kidney Cancers with New Data at 2026 ASCO GU Cancers Symposium.
Read full article